Ultra-thinly traded Vaccinex (VCNX +26%) is up on over 50% higher volume, albeit on turnover of only ~13K shares, on the heels of thee presentations at AACR related to its anti-SEMA4D technology.
The company states that the details of each of the three are on its website, but only the titles appear.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.